( Natural News ) Startups in the field of bioengineering are attempting to get the Food and Drug Administration (FDA) to approve trials involving transplanting animal organs into humans .
One of the first-of-its-kind xenotransplants occurred in January 2022, when 57-year-old David Bennett, a man with late-stage heart failure from Maryland, received the heart of a pig.
Bennett was too sick to be eligible for a traditional human transplant , which is why a biotech company, United Therapeutics, genetically engineered the heart of a pig to reduce the risk of immune rejection. This heart was then transplanted into him.
The initial results of the operation were promising, but Bennett died within two months after the operation. His official cause of death is still being determined, with mainstream medical opinions claiming it is not due to organ rejection.United Therapeutics is undeterred by Bennett’s death, and the company believes that formal trials of […]
Excerpt Sourced From: www.naturalnews.com
